日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Indole-3-propionic acid links gut dysfunction to diabetic retinopathy: a biomarker and novel therapeutic approach

吲哚-3-丙酸将肠道功能障碍与糖尿病视网膜病变联系起来:一种生物标志物和一种新的治疗方法

Prasad, Ram; Adu-Rutledge, Yvonne; Ziani, Borhane; Floyd, Jason L; Ready, Edgar L; Paul, Sarbodeep; Sheini, Fadeela; Sharma, Rati; Rosencrans, Robert F; Li Calzi, Sergio; Sielski, Micheli Severo; Medawar, Nicholas G; Dutta, Roshan; Johnson, Emory Brennis; Qi, Xiaoping; Bansal, Mohit; Lamendella, Regina; Wright, Justin R; Verma, Suresh Kumar; Boulton, Michael E; Stevens, Bruce R; Vander Kooi, Craig W; Sun, Ramon C; Oudit, Gavin Y; Li, Qiuhong; Grant, Maria B

Autonomous AI-assisted diabetic retinopathy screening at primary care is associated with increased presentation to eye care by at risk patients

在基层医疗机构开展的自主人工智能辅助糖尿病视网膜病变筛查与高危患者就诊眼科的增加相关

Leong, Ariel; Wolf, Risa M; Channa, Roomasa; Wang, Jiangxia; Lehmann, Harold; Abramoff, Michael D; Liu, T Y Alvin

Single-Cell RNA Sequencing of Retina Reveals Nna1 Upregulation in Myopic Diabetic Retinopathy as a Protective Factor Against Diabetic Damage

单细胞RNA测序揭示近视性糖尿病视网膜病变中Nna1上调是抵抗糖尿病损伤的保护因素

Xie, Lihui; Cai, Yingjun; Chen, Bolin; Li, Bowen; Zou, Jing; Xu, Huizhuo

Association of HbA(1c) and an updated glucose management indicator (uGMI) with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study

糖化血红蛋白 (HbA1c) 和更新的血糖管理指标 (uGMI) 与 1 型糖尿病成人糖尿病视网膜病变发生率的相关性:一项纵向研究

Shah, Viral N; Xu, Yongjin; Dabiri, Yaghoub; Mohanadas, Hemanth P; Cheng, Alan; Dunn, Timothy C

Clinical trial landscape of diabetic retinopathy: global advancements and future directions

糖尿病视网膜病变临床试验概况:全球进展与未来方向

Cao, Haixing; Zhang, Yujie; Zhang, Naiwen; Ma, Xiang

Telemedicine for diabetic retinopathy screening

远程医疗在糖尿病视网膜病变筛查中的应用

Shahbazian, Angela; Sherstinsky, Mark; Ison, Elysia M; Han, Genie; Kruoch, Zanna; Hatcher, Kensington; Lawrenson, John G

Brolucizumab in the Treatment of Proliferative Diabetic Retinopathy: The CONDOR Randomized Clinical Trial

Brolucizumab治疗增殖性糖尿病视网膜病变:CONDOR随机临床试验

Wolf, Sebastian; Chen, Youxin; Li, Xiaorong; Shimura, Masahiko; Sakamoto, Taiji; Wykoff, Charles C; Emanuelli, Andres; Salehi-Had, Hani; Yan, Kang; Kovacic, Lidija; Kim, Yongsoo

Ultra-Widefield Fluorescein Angiographic Quantitative Leakage Parameters and Clinical Outcomes in Nonproliferative Diabetic Retinopathy

超广角荧光血管造影定量渗漏参数与非增殖性糖尿病视网膜病变的临床结局

Ehlers, Justis P; Josic, Kristin; Aiello, Lloyd P; Amine, Reem; Indurkar, Asmita; Martin, Alison A; Matar, Karen; Silva, Paolo S; Sun, Jennifer K

Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy

糖尿病视网膜病变中的视网膜敏感性和视网膜灌注

Hamilton-Perais, Jennifer A; Wright, David M; Lim, Amelia; Mohite, Ajay; Reid, Gerard; Hillis, Pearse; Sheeran, Cora; Lois, Noemi

Cathepsin H as a causal risk factor and therapeutic target in proliferative diabetic retinopathy

组织蛋白酶H作为增殖性糖尿病视网膜病变的致病风险因素和治疗靶点

Zhou, Qihang; Yang, Fan; Guo, Shurong; Zhou, Xiaoyin; Jiang, Fanying; Li, Zhenping; Li, Xuepei; Zhao, Yunjiao; Lai, Yitao; Gong, Haijun; Lan, Yuqing